Flow’s FL-100 Earns FDA PMA — First Prescription At-Home tDCS Device Cleared for Depression

On December 8, 2025, Flow Neuroscience's FL-100 received FDA Premarket Approval (PMA P230024), becoming the first at-home, clinician-supervised tDCS device cleared for treating major depressive disorder. The de...



























